Immunotherapy Company 3D Medicines Raises Funds After Spin-Off

This Data Is Locked!

This area is available only to Subscribers.

3D Medicines, a tumor immunotherapy company, has recently completed the first round of financing after a US$140 million spin-off, which is approximately RMB970 million yuan.... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?